Evidence map›Paper›PMID 35690777›Full record

ArticleJournal of neuroinflammation2022

Adaptation of prelimbic cortex mediated by IL-6/STAT3/Acp5 pathway contributes to the comorbidity of neuropathic pain and depression in rats.

Yu-Ting Zhao, Jie Deng, He-Ming Liu, Jia-You Wei, Hai-Ting Fan, Meng Liu, Ting Xu, Ting-Feng Chen, Jing-Yi He, Wei-Ming Sun and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. (Ba,Ca)(Ti,Sn)OFrontiers in cellular neuroscience · 2026
    Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Pathology of pain and its implications for therapeutic interventions.Signal transduction and targeted therapy · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Yu-Ting Zhao *Neuroscience Program, Zhongshan School of Medicine, The Fifth Affiliated Hospital, Sun Yat-Sen University, Zhongshan Rd. 2, Guangzhou, China.
Jie Deng *Neuroscience Program, Zhongshan School of Medicine, The Fifth Affiliated Hospital, Sun Yat-Sen University, Zhongshan Rd. 2, Guangzhou, China.
He-Ming LiuNeuroscience Program, Zhongshan School of Medicine, The Fifth Affiliated Hospital, Sun Yat-Sen University, Zhongshan Rd. 2, Guangzhou, China.
Jia-You WeiNeuroscience Program, Zhongshan School of Medicine, The Fifth Affiliated Hospital, Sun Yat-Sen University, Zhongshan Rd. 2, Guangzhou, China. weijy33@mail.sysu.edu.cn.
Hai-Ting FanNeuroscience Program, Zhongshan School of Medicine, The Fifth Affiliated Hospital, Sun Yat-Sen University, Zhongshan Rd. 2, Guangzhou, China.
Meng LiuGuangzhou First People's Hospital, Guangzhou, China.
Ting XuNeuroscience Program, Zhongshan School of Medicine, The Fifth Affiliated Hospital, Sun Yat-Sen University, Zhongshan Rd. 2, Guangzhou, China.
Ting-Feng ChenGuangzhou First People's Hospital, Guangzhou, China.
Jing-Yi HeGuangzhou First People's Hospital, Guangzhou, China.
Wei-Ming SunNeuroscience Program, Zhongshan School of Medicine, The Fifth Affiliated Hospital, Sun Yat-Sen University, Zhongshan Rd. 2, Guangzhou, China.
Tao-Yu JiaNeuroscience Program, Zhongshan School of Medicine, The Fifth Affiliated Hospital, Sun Yat-Sen University, Zhongshan Rd. 2, Guangzhou, China.
Xue-Qin ZhangDepartment of Applied Psychology, The Affiliated Brain Hospital of Guangzhou Medical University, Xinzao Road, Panyu District, Guangzhou, China. gzzxq2005@126.com.
Wen-Jun XinNeuroscience Program, Zhongshan School of Medicine, The Fifth Affiliated Hospital, Sun Yat-Sen University, Zhongshan Rd. 2, Guangzhou, China. xinwj@mail.sysu.edu.cn.ORCID http://orcid.org/0000-0002-5380-8738
Sun Yat-sen University · CNGuangzhou First People's Hospital · CNGuangzhou Medical University · CN

Funding

National Natural Science Foundation of China 31970936
6 · The paper itself

Abstract

backgroundThe adaption of brain region is fundamental to the development and maintenance of nervous system disorders. The prelimbic cortex (PrL) participates in the affective components of the pain sensation. However, whether and how the adaptation of PrL contributes to the comorbidity of neuropathic pain and depression are unknown.

methodsUsing resting-state functional magnetic resonance imaging (rs-fMRI), genetic knockdown or overexpression, we systematically investigated the activity of PrL region in the pathogenesis of neuropathic pain/depression comorbid using the combined approaches of immunohistochemistry, electrophysiology, and behavior.

resultsThe activity of PrL and the excitability of pyramidal neurons were decreased, and the osteoclastic tartrate-resistant acid phosphatase 5 (Acp5) expression in PrL neurons was upregulated following the acquisition of spared nerve injury (SNI)-induced comorbidity. Genetic knockdown of Acp5 in pyramidal neurons, but not parvalbumin (PV) neurons or somatostatin (SST) neurons, attenuated the decrease of spike number, depression-like behavior and mechanical allodynia in comorbidity rats. Overexpression of Acp5 in PrL pyramidal neurons decreased the spike number and induced the comorbid-like behavior in naïve rats. Moreover, the expression of interleukin-6 (IL-6), phosphorylated STAT3 (p-STAT3) and acetylated histone H3 (Ac-H3) were significantly increased following the acquisition of comorbidity in rats. Increased binding of STAT3 to the Acp5 gene promoter and the interaction between STAT3 and p300 enhanced acetylation of histone H3 and facilitated the transcription of Acp5 in PrL in the modeled rodents. Inhibition of IL-6/STAT3 pathway prevented the Acp5 upregulation and attenuated the comorbid-like behaviors in rats.

conclusionsThese data suggest that the adaptation of PrL mediated by IL-6/STAT3/Acp5 pathway contributed to the comorbidity of neuropathic pain/depression induced by SNI.

Indexed as

Interleukin-6NeuralgiaAcid PhosphataseAnimalsComorbidityDepressionHistonesRatsSTAT3 Transcription FactorTartrate-Resistant Acid PhosphataseAcid PhosphataseAcp5 protein, ratHistonesIl6 protein, ratInterleukin-6Stat3 protein, ratSTAT3 Transcription FactorTartrate-Resistant Acid PhosphataseComorbidDepressionIL-6Neuropathic painPrelimbic cortexSpared nerve injury

Identifiers

PMID35690777
PMCPMC9188197
OpenAlexW4282939944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.